Adverse event | Grade 1–2, n (%) | Grade 3, n (%) | Grade 4–5, n (%) |
---|---|---|---|
White blood cell decreased | 42(86%) | 1(2%) | 0(0%) |
Neutrophil count decreased | 28(57%) | 1(2%) | 0(0%) |
Anemia | 38(76%) | 0(0%) | 0(0%) |
Platelet count decreased | 30(61%) | 1(2%) | 0(0%) |
Blood bilirubin increased | 14(29%) | 5(10%) | 0(0%) |
AST increased | 22(45%) | 5(10%) | 0(0%) |
ALT increased | 25(51%) | 6(12%) | 0(0%) |
Hypoalbuminemia | 32(65%) | 1(2%) | 0(0%) |
Serum AMY increased | 10(20%) | 4(8%) | 0(0%) |
Allergic reaction | 3(6%) | 1(2%) | 0(0%) |
Fatigue | 20(41%) | 0(0%) | - |
Anorexia | 24(49%) | 0(0%) | 0(0%) |
Diarrhea | 5(11%) | 0(0%) | 0(0%) |
Mucositis/stomatitis | 2(4%) | 0(0%) | 0(0%) |
Nausea | 22(45%) | 0(0%) | - |
Vomiting | 8(16%) | 0(0%) | 0(0%) |
Febrile neutropenia | - | 0(0%) | 0(0%) |
Biliary tract infection | - | 8(16%) | 0(0%) |